Contrasting Sotera Health (NASDAQ:SHC) and Bullfrog AI (NASDAQ:BFRGW)

Bullfrog AI (NASDAQ:BFRGW) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation and analyst recommendations.

Institutional and Insider Ownership

91.0% of Sotera Health shares are held by institutional investors. 15.4% of Sotera Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Bullfrog AI and Sotera Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	N/A	N/A
Sotera Health	13.44%	40.12%	7.55%

Analyst Ratings

This is a summary of recent ratings and price targets for Bullfrog AI and Sotera Health, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	0	0	0	0	0.00
Sotera Health	0	3	8	0	2.73

Sotera Health has a consensus price target of $21.50, indicating a potential upside of 12.97%. Given Sotera Health’s stronger consensus rating and higher probable upside, analysts plainly believe Sotera Health is more favorable than Bullfrog AI.

Earnings and Valuation

This table compares Bullfrog AI and Sotera Health”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$116,670.00	N/A	N/A	N/A	N/A
Sotera Health	$1.16 billion	4.67	$77.94 million	$0.57	33.39

Sotera Health has higher revenue and earnings than Bullfrog AI.

Summary

Sotera Health beats Bullfrog AI on 9 of the 9 factors compared between the two stocks.

About Bullfrog AI

BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.